Focalin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Dexmethylphenidate Hydrochloride.
| Product ID | 0078-0382_4ca8780c-8d1c-4c8f-a027-a26b97acdce5 |
| NDC | 0078-0382 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Focalin |
| Generic Name | Dexmethylphenidate Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2001-11-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021278 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | DEXMETHYLPHENIDATE HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2001-11-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021278 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2001-11-30 |
| Ingredient | Strength |
|---|---|
| DEXMETHYLPHENIDATE HYDROCHLORIDE | 10 mg/1 |
| SPL SET ID: | 7c552f11-e24a-4d9b-bb8d-be10c928eca8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0380 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0381 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0382 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0430 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0431 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0432 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0433 | Focalin | dexmethylphenidate hydrochloride |
| 0078-0434 | Focalin | dexmethylphenidate hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FOCALIN 78056439 2978115 Live/Registered |
Novartis AG 2001-04-03 |